261 related articles for article (PubMed ID: 9649675)
1. Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
Nasca MR; Micali G; Pulvirenti N; Licastro Cicero R
Eur J Dermatol; 1998 Mar; 8(2):125-6. PubMed ID: 9649675
[TBL] [Abstract][Full Text] [Related]
2. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
[TBL] [Abstract][Full Text] [Related]
3. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
4. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
Valsecchi R; Pansera B; Rossi A; Cainelli T
G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
6. Topical immunotherapy of alopecia areata. A follow-up study.
Valsecchi R; Cainelli T; Foiadelli L; Rossi A
Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
[TBL] [Abstract][Full Text] [Related]
7. Treatment of alopecia areata with squaric acid dibutylester.
Caserio RJ
Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
Ajith C; Gupta S; Kanwar AJ
J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
[TBL] [Abstract][Full Text] [Related]
9. Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata.
Guerra L; Pacifico V; Calabresi V; De Luca N; Castiglia D; Angelo C; Zambruno G; Di Zenzo G
Br J Dermatol; 2017 Feb; 176(2):491-494. PubMed ID: 27208509
[TBL] [Abstract][Full Text] [Related]
10. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
Miranda A; Mato F; Quiñones PA
Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
[TBL] [Abstract][Full Text] [Related]
11. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
12. Treatment of alopecia areata with squaric acid dibutylester.
Hill ND; Bunata K; Hebert AA
Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
[TBL] [Abstract][Full Text] [Related]
13. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Inui S; Nakajima T; Toda N; Itami S
J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
[TBL] [Abstract][Full Text] [Related]
14. Determination of the sildenafil effect on alopecia areata in childhood: An open-pilot comparison study.
Sarifakioglu E; Degim IT; Gorpelioglu C
J Dermatolog Treat; 2006; 17(4):235-7. PubMed ID: 16971319
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of alopecia areata with diphencyprone].
Suditu G; Toma A; Voiculescu M
Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
[TBL] [Abstract][Full Text] [Related]
16. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
Chua SH; Goh CL; Ang CB
Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
Sakai K; Fukushima S; Mizuhashi S; Jinnin M; Makino T; Inoue Y; Ihn H
Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
[TBL] [Abstract][Full Text] [Related]
18. Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
Pardasani AG; Turner E; McMichael AJ
Arch Dermatol; 2001 Jul; 137(7):970-2. PubMed ID: 11453831
[No Abstract] [Full Text] [Related]
19. [DNCB therapy of alopecia areata].
Happle R
Z Hautkr; 1979 May; 54(10):426-9. PubMed ID: 314203
[TBL] [Abstract][Full Text] [Related]
20. Topical immunotherapy with squaric acid dibutylester: unusual hair pigmentary changes in two cases of alopecia areata.
Mastrolonardo M; Diaferio A
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):186. PubMed ID: 12046838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
